GlobeX Data (OTCQB: SWISF- CSE: SWIS) CEO Alain Ghiai joined Steve Darling from Proactive to bring news the stem cell company Hemostemix, has placed an order for the Sekur encrypted messaging and secure email platform.
Ghiai telling Proactive Hemostemix, which is in the advanced stages of its research in stem cell therapy, has been looking for an alternate secure and private communications solution to communicate with regulatory authorities, such as the USFDA.